Neuronetics is trading 5.3% down now at $2.79, with no clear company-specific announcement, earnings update, analyst action, or other direct catalyst dated August 31, 2026 identified.
- Recent coverage concerns August 11 second-quarter results and an August 14 insider purchase, both predating the decline.
- Broader markets are modestly lower, but evidence is insufficient to attribute the move confidently to macro sentiment.